Braidwell »

EXACT Sciences Corporation shares owned by Braidwell

Quarter-by-quarter ownership of EXACT Sciences Corporation (EXAS) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in EXACT Sciences Corporation

Tip: Access up to 7 years of quarterly data

All positions including EXACT Sciences Corporation held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in EXACT Sciences Corporation by Braidwell

Quarter filed Position value Share count Share price at filing
2024-09-30 $20M 286k 68.12
2024-06-30 $48M 1.1M 42.25

More positions owned by Braidwell

Guardant Health Note11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Novocure Note11/0 (Principal)
Cg Oncology (CGON)
Nuvasive Note 0.375% 3/1 (Principal)
Xenon Pharmaceuticals (XENE)
Neurocrine Biosciences (NBIX)
Neogenomics Note 0.250% 1/1 (Principal)
Apogee Therapeutics (APGE)
Apellis Pharmaceuticals (APLS)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Dexcom Note 0.375% 5/1 (Principal)
Align Technology (ALGN)
Guardant Health (GH)
Insulet Corp Note 0.375% 9/0 (Principal)

View all positions for Braidwell

Top funds holding EXACT Sciences Corporation

Vanguard Group
Capital World Investors
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
William Blair Investment Management
Artisan Partners Limited Partnership
T. Rowe Price Investment Management
T. Rowe Price Associates
Geode Capital Management
Champlain Investment Partners
Holocene Advisors
Macquarie Group
CAM Group Holding A/S

View all funds holding EXACT Sciences Corporation